Generics Market Research
The generics industry has developed significantly over the past decade and represents an integral part of the broader prescription pharmaceutical market. Generic drugs (short: generics) are drugs which are produced and distributed without patent protection. Generic drugs are cost-effective for patients, as well as insurance companies.
Research highlights that the generics industry posted compound annual growth rates (CAGR) of 10.3 percent with strong revenues, in the period 2005-2009. The global generics market was estimated to be worth approximately $80 billion in 2009 and this industry has greatly evolved in the last decade.
While the generics industry has exhibited strong growth in recent years, experts forecast that sales growth is likely to start declining between the 2009 and 2015 period with a compound annual growth rate (CAGR) of 5%.
The Generics market research reports incorporate trend analysis, statistics, market size information, industry growth rates, as well as market share of competitors. The comprehensive research also goes on to examine details such as technology & systems and domestic & international markets.
The study is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, comprehensive analysis of the key trends and competitive landscape, and profiles of the leading companies.